We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Pathogenic mechanism of the FIG4 mutation responsible for Charcot-Marie-Tooth disease CMT4J.

PLoS genetics | Jun 9, 2011

CMT4J is a severe form of Charcot-Marie-Tooth neuropathy caused by mutation of the phosphoinositide phosphatase FIG4/SAC3. Affected individuals are compound heterozygotes carrying the missense allele FIG4-I41T in combination with a null allele. Analysis using the yeast two-hybrid system demonstrated that the I41T mutation impairs interaction of FIG4 with the scaffold protein VAC14. The critical role of this interaction was confirmed by the demonstration of loss of FIG4 protein in VAC14 null mice. We developed a mouse model of CMT4J by expressing a Fig4-I41T cDNA transgene on the Fig4 null background. Expression of the mutant transcript at a level 5 × higher than endogenous Fig4 completely rescued lethality, whereas 2 × expression gave only partial rescue, providing a model of the human disease. The level of FIG4-I41T protein in transgenic tissues is only 2% of that predicted by the transcript level, as a consequence of the protein instability caused by impaired interaction of the mutant protein with VAC14. Analysis of patient fibroblasts demonstrated a comparably low level of mutant I41T protein. The abundance of FIG4-I41T protein in cultured cells is increased by treatment with the proteasome inhibitor MG-132. The data demonstrate that FIG4-I41T is a hypomorphic allele encoding a protein that is unstable in vivo. Expression of FIG4-I41T protein at 10% of normal level is sufficient for long-term survival, suggesting that patients with CMT4J could be treated by increased production or stabilization of the mutant protein. The transgenic model will be useful for testing in vivo interventions to increase the abundance of the mutant protein.

Pubmed ID: 21655088 RIS Download

Mesh terms: Alleles | Animals | Autophagy | Charcot-Marie-Tooth Disease | Fibroblasts | Flavoproteins | Gliosis | Humans | Intracellular Signaling Peptides and Proteins | Mice | Mice, Transgenic | Models, Animal | Mutation | Proteasome Endopeptidase Complex | Proteasome Inhibitors | Transfection

Research resources used in this publication

Research tools detected in this publication

Data used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, Id: R56 NS04733
  • Agency: NIGMS NIH HHS, Id: T32 GM007863
  • Agency: NIGMS NIH HHS, Id: T32 GM008322
  • Agency: NIGMS NIH HHS, Id: T32 GM 008322
  • Agency: NINDS NIH HHS, Id: R01 NS64015
  • Agency: NIGMS NIH HHS, Id: T32 GM07863
  • Agency: NINDS NIH HHS, Id: R01 NS064015
  • Agency: NIGMS NIH HHS, Id: R01 GM024872
  • Agency: NIGMS NIH HHS, Id: T32 GM007544
  • Agency: NIGMS NIH HHS, Id: R01 GM050403
  • Agency: NIGMS NIH HHS, Id: R01 GM24872

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.

Transgenic Animal Model Core

A service for preparing genetically modified mice and rats for investigators at the University of Michigan. These mice models are typically used to study gene function, gene expression, gene regulation, and for the development of animal models of human disease and gene therapy reagents. TAMC provide access to their micromanipoulation and embryos stem cell workstations along with necessary reagents such as specialized plasmids, embryonic stem (ES) cell lines, FBS, and feeder cells certified for ES cell culture.


View all literature mentions